Should a 28-year-old who missed the meningococcal conjugate vaccine (MenACWY) booster receive it now?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Should a 28-Year-Old Receive the Missed Meningococcal Booster?

No, a 28-year-old who missed the meningococcal booster dose does not need to receive it now, as routine MenACWY vaccination is not recommended for adults aged ≥24 years without specific risk factors.

Understanding the Recommendation

The current ACIP guidelines are clear about age-based meningococcal vaccination 1, 2:

  • Routine adolescent vaccination consists of MenACWY at age 11-12 years with a booster at age 16 years
  • Catch-up vaccination may be administered to persons aged 19-21 years who have not received a dose after their 16th birthday
  • After age 23 years, MenACWY is not routinely recommended unless specific risk factors are present

The Critical Age Cutoff

Adolescents who receive their first dose of meningococcal conjugate vaccine at or after 16 years of age do not need a booster dose 3. This is because:

  • The vaccine provides durable immunity when given at age ≥16 years
  • Disease incidence decreases substantially after adolescence/young adulthood
  • The highest risk period for meningococcal disease is ages 16-23 years

When Adults ≥24 Years SHOULD Receive MenACWY

Your 28-year-old patient should receive MenACWY only if they have 1:

High-risk medical conditions:

  • Persistent complement component deficiencies (C3, C5-C9, properdin, factor D, factor H)
  • Complement inhibitor use (e.g., eculizumab, ravulizumab)
  • Functional or anatomic asplenia
  • HIV infection

Situational risk factors:

  • Travel to or residence in hyperendemic/epidemic areas (e.g., sub-Saharan Africa's "meningitis belt")
  • Microbiologists routinely exposed to Neisseria meningitidis
  • Community outbreak of vaccine-preventable serogroup
  • First-year college students living in residence halls (through age 21 only)

Clinical Decision Algorithm

For your 28-year-old patient:

  1. Assess vaccination history: Did they receive any MenACWY doses during adolescence?

  2. Evaluate risk factors: Do they have any of the high-risk conditions or situational exposures listed above?

  3. If NO risk factors present: Do not administer MenACWY. Reassure the patient that routine vaccination is not indicated at their age.

  4. If risk factors ARE present: Administer a 2-dose primary series of MenACWY (any formulation) given 8-12 weeks apart, followed by boosters every 5 years if risk persists 1

Important Caveats

Licensing considerations: While MenACWY-D and MenACWY-CRM are licensed only for persons aged 9 months-55 years, and MenACWY-TT for persons aged ≥2 years, vaccination of persons aged ≥56 years is considered off-label but may be appropriate for high-risk individuals 1.

Don't confuse with MenB: The question specifically addresses MenACWY (the conjugate vaccine covering serogroups A, C, W, Y). MenB vaccines have different indications and are generally recommended for ages 16-23 years based on shared clinical decision-making or for high-risk individuals aged ≥10 years 1, 4.

College students: If your patient is a first-year college student living in a residence hall and is ≤21 years old, they should receive a dose if their last vaccination was before age 16 3. However, at age 28, this no longer applies.

References

Related Questions

What meningococcal vaccination schedule is recommended for a 16‑year‑old male who has not received any meningococcal vaccine yet?
What is the recommended MenACWY (meningococcal A, C, W, Y) vaccination schedule for an adult man traveling to Europe?
For a healthy 16‑year‑old male with no prior meningococcal vaccination, is a two‑dose meningococcal vaccine schedule recommended?
Does a 17‑year‑old who has never received MenACWY (meningococcal conjugate vaccine covering serogroups A, C, W, Y) need a second dose?
Is Menveo (meningococcal conjugate vaccine) a live vaccine?
What is the likelihood that a few scattered ground‑glass nodules up to 7 mm in the left upper lobe, stable for one year, are malignant in a patient with a seven‑year smoking history?
What is the most likely diagnosis in a neutropenic patient with fever, elevated troponin, and rhabdomyolysis?
For a 43‑year‑old man recovering from a manic episode with psychotic features and currently stable on lithium, olanzapine 20 mg daily, and quetiapine, how should his medication regimen be adjusted to reduce daytime sedation while maintaining mood stability?
What should we tell a patient with HIV, B12 deficiency, chronic left‑sided low back pain, erectile dysfunction, hypercholesterolemia, testicular hypofunction, thyroid nodule, asymptomatic microscopic hematuria, and a history of opioid use who presented to the emergency department with opioid‑withdrawal‑type symptoms after taking bupropion (Wellbutrin) and who reports heavy kratom use, that they should stop kratom, consider inpatient detoxification (potentially covered by Oscar insurance), and how to manage their other medical conditions?
How should I manage a 57-year-old African American man with chronic bilateral lower‑extremity edema (present for about a year, worsening over the past 3 days), hypertension (blood pressure 146/82) currently on amlodipine 10 mg once daily, naproxen 375 mg once daily, and tamsulosin 0.4 mg once daily, who smokes daily and uses heroin (approximately two bags per day), with no alcohol or cocaine use?
For a patient with acute kidney injury receiving vancomycin dosed according to trough levels, how often should the dose be adjusted—daily if a trough is drawn each day?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.